PCSK9 Levels and Metabolic Profiles in Elderly Subjects with Different Glucose Tolerance under Statin Therapy

PCSK9 Levels and Metabolic Profiles in Elderly Subjects with Different Glucose Tolerance under Statin Therapy

Proprotein convertase subtilisin/kexin type 9 (PCSK9) degrades low-density lipoprotein cholesterol (LDL-C) receptors, and thus regulates the LDL-C levels in the circulation. Type 2 diabetics often have elevated LDL-C levels. However, the functions of PCSK9 in patients with alterations of glu-cose me...

Full description

Bibliographic Details
Main Authors: Kari A. Mäkelä, Jari Jokelainen, Ville Stenbäck, Juha Auvinen, Marjo-Riitta Järvelin, Mikko Tulppo, Juhani Leppäluoto, Sirkka Keinänen-Kiukaanniemi, Karl-Heinz Herzig
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
PCSK9
prediabetes
type 2 diabetes
LDL cholesterol
statin therapy
elderly
Online Access:https://www.mdpi.com/2077-0383/10/5/994

Internet

https://www.mdpi.com/2077-0383/10/5/994

Similar Items